[PDF][PDF] Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
Human monoclonal antibodies are safe, preventive, and therapeutic tools that can be rapidly
developed to help restore the massive health and economic disruption caused by the …
developed to help restore the massive health and economic disruption caused by the …
[HTML][HTML] Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males
Background While SARS-CoV-2 similarly infects men and women, COVID-19 outcome is less
favorable in men. Variability in COVID-19 severity may be explained by differences in the …
favorable in men. Variability in COVID-19 severity may be explained by differences in the …
[HTML][HTML] Clinical and molecular characterization of COVID-19 hospitalized patients
E Benetti, A Giliberti, A Emiliozzi, F Valentino… - Plos one, 2020 - journals.plos.org
Clinical and molecular characterization by Whole Exome Sequencing (WES) is reported in
35 COVID-19 patients attending the University Hospital in Siena, Italy, from April 7 to May 7, …
35 COVID-19 patients attending the University Hospital in Siena, Italy, from April 7 to May 7, …
[HTML][HTML] Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a …
…, G Baldin, A Ciccullo, D Moschese, A Emiliozzi… - BMC infectious …, 2019 - Springer
Background Direct comparisons between lamivudine plus bPIs and lamivudine plus dolutegravir
as maintenance strategies in virologically-suppressed HIV positive patients are lacking. …
as maintenance strategies in virologically-suppressed HIV positive patients are lacking. …
Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients
In the absence of approved drugs or vaccines, there is a pressing need to develop tools for
therapy and prevention of Covid-19. Human monoclonal antibodies have very good …
therapy and prevention of Covid-19. Human monoclonal antibodies have very good …
[PDF][PDF] Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from …
…, G Baldin, A Borghetti, A Dusina, A Emiliozzi… - Infez Med, 2018 - infezmed.it
Bone toxicity is a growing problem in HIV patients, given the increasing life expectancy; in
particular, decrease in bone mineral density (BMD) and higher rate of osteoporosis and …
particular, decrease in bone mineral density (BMD) and higher rate of osteoporosis and …
comparing Lamivudine+ Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as switch strategies: preliminary results from clinical practice
…, A D'Angelillo, A Dusina, A Emiliozzi… - AIDS Research and …, 2021 - liebertpub.com
We tried to investigate and compare the safety of a dual therapy (DT) with dolutegravir+lamivudine
(DTG +3TC) versus bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF). …
(DTG +3TC) versus bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF). …
[HTML][HTML] Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: A phase 3, randomized, open-labeled, multi-center study (ESCAPE …
…, C Del Borgo, F Di Gennaro, A Emiliozzi… - …, 2023 - thelancet.com
Background Among interleukin-6 inhibitors suggested for use in COVID-19, there are few
robust evidences for the efficacy of sarilumab. Herein, we evaluated the efficacy and safety of …
robust evidences for the efficacy of sarilumab. Herein, we evaluated the efficacy and safety of …
Hepatitis C virus–related factors associated WITH cognitive performance in HIV-HCV-coinfected patients
…, E Colella, D Moschese, M Valsecchi, A Emiliozzi… - Journal of …, 2019 - Springer
The contribution of HCV-related variables to cognitive impairment in HIV-HCV-coinfected
patients has been poorly investigated. We selected HIV-HCV-coinfected patients undergoing …
patients has been poorly investigated. We selected HIV-HCV-coinfected patients undergoing …
An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy
…, G Baldin, A Borghetti, D Moschese, A Emiliozzi… - HIV …, 2018 - Wiley Online Library
Objectives Italy is a low‐incidence region for hepatitis A; however, during the last 2 years an
increase in the incidence of hepatitis A virus ( HAV ) infection was reported in Europe. The …
increase in the incidence of hepatitis A virus ( HAV ) infection was reported in Europe. The …